No photo of Philip Regan

Philip Regan

Dr

20112018
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2018

5 Citations (Scopus)

Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder

Mahmood, U., Ahn, S., Yang, E-J., Choi, M., Kim, H., Regan, P., Cho, K. & Kim, H-S., 1 Feb 2018, In : Pulmonary Pharmacology & Therapeutics. 128, p. 110-121 12 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Impairment of Release Site Clearance within the Active Zone by Reduced SCAMP5 Expression Causes Short-Term Depression of Synaptic Release

Park, D., Lee, U., Cho, E., Zhao, H., Kim, J. A., Lee, B. J., Regan, P., Ho, W-K., Cho, K. & Chang, S., 20 Mar 2018, In : Cell Reports. 22, 12, p. 3339-3350 12 p.

Research output: Contribution to journalArticle

Open Access

Postsynaptic p47phox regulates long-term depression in the hippocampus

Yi, J. H., Kim, D. H., Piers, T. M., Kim, S. C., Whitcomb, D. J., Regan, P. & Cho, K., 28 Aug 2018, In : Cell discovery. 4, 44.

Research output: Contribution to journalArticle

Open Access
12 Citations (Scopus)

Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease

Whitehead, G., Regan, P., Whitcomb, D. J. & Cho, K., 1 Jan 2017, In : Neuropharmacology. 112, Pt A, p. 221-227 7 p.

Research output: Contribution to journalReview article

9 Citations (Scopus)

Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus

Yi, J. H., Brown, C., Whitehead, G., Piers, T., Lee, Y. S., Perez, C. M., Regan, P., Whitcomb, D. J. & Cho, K., 1 Jul 2017, In : Pulmonary Pharmacology & Therapeutics. 121, p. 42-51 10 p.

Research output: Contribution to journalArticle

Open Access